QGEN Stock Financial Analysis - Qiagen N.V. (BRSE) Stock

Overview

Qiagen N.V., headquartered in Venlo, the Netherlands, is a prominent global provider in the field of Sample to Insight solutions, primarily serving the molecular diagnostics and life sciences industries. The company specializes in developing and commercializing a broad array of products, including sample and assay technologies, for extracting, isolating, and preparing DNA, RNA, and proteins from biological samples for analysis. A key focus of Qiagen's operations is the advancement of molecular diagnostics, with significant investment in technologies that facilitate disease prevention, more precise diagnoses, and personalized healthcare. Qiagen's projects typically emphasize solutions for infectious disease testing and detection of genetic variations, supporting research in areas such as oncology, human identification, and genetic disorders.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for Qiagen N.V. as of 30 June 2025 is 2,040.07 MM.
The operating income for Qiagen N.V. as of 30 June 2025 is 821.83 MM.
The net income for Qiagen N.V. as of 30 June 2025 is 373.39 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	2,040.07	821.83	373.39
2025-03-31	2,002.87	523.19	93.68
2024-12-31	1,978.21	494.96	83.59
2024-09-30	1,966.17	471.97	92.93
2024-06-30	1,940.20	166.58	72.69
2024-03-31	1,938.71	440.97	336.94
2023-12-31	1,965.31	445.25	341.30
2023-09-30	1,954.13	436.77	332.48
2023-06-30	1,977.87	453.45	337.06
2023-03-31	1,998.53	466.32	352.93
2022-12-31	2,141.52	576.62	423.21
2022-09-30	2,225.93	646.98	488.01
2022-06-30	2,261.05	664.37	538.75
2022-03-31	2,312.84	707.77	563.14
2021-12-31	2,251.66	657.85	512.60
2021-09-30	2,240.49	657.74	310.55
2021-06-30	2,189.51	658.39	479.87
2021-03-31	2,065.45	627.97	448.58
2020-12-31	1,870.35	537.47	359.19
2020-09-30	1,712.58	459.10	191.44
2020-06-30
2020-03-31

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31
2024-12-31		0.37
2024-09-30	0.43	0.43
2024-06-30	0.34	0.34
2024-03-31	1.56	1.55
2023-12-31	1.59	1.57
2023-09-30	1.55	1.54
2023-06-30	1.57	1.56
2023-03-31	1.64	1.63
2022-12-31	1.97	1.95
2022-09-30	2.28	2.24
2022-06-30	2.51	2.46
2022-03-31	2.62	2.57
2021-12-31	2.38	2.34
2021-09-30	1.44	1.40
2021-06-30	2.23	2.17
2021-03-31	2.08	2.03
2020-12-31	1.67	1.62
2020-09-30	0.89	0.88
2020-06-30	0.06	0.07
2020-03-31	-0.15	-0.15

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Qiagen N.V. as of 30 June 2025 is 675.03 MM.
The cash from investing activities for Qiagen N.V. as of 30 June 2025 is -159.74 MM.
The cash from financing activities for Qiagen N.V. as of 30 June 2025 is -318.12 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	675.03	-159.74	-318.12
2025-03-31	680.21	-135.58	-417.51
2024-12-31	673.55	-249.23	-422.90
2024-09-30	633.41	-300.90	58.64
2024-06-30	575.75	178.51	-828.00
2024-03-31	520.61	352.62	-716.09
2023-12-31	459.45	-87.66	-433.83
2023-09-30	432.41	-153.73	-972.76
2023-06-30	519.30	-446.54	-163.65
2023-03-31	579.78	-854.36	-124.97
2022-12-31	715.26	-726.76	-125.80
2022-09-30	826.39	-516.22	362.17
2022-06-30	770.33	-690.81	-121.77
2022-03-31	754.77	-623.93	-147.60
2021-12-31	639.00	-202.43	-150.37
2021-09-30	744.72	-362.23	-236.51
2021-06-30	592.24	-455.07	-77.21
2021-03-31	570.52	-350.43	-100.36
2020-12-31	457.81	-443.28	-50.13
2020-09-30	297.52	-469.49	-60.04
2020-06-30
2020-03-31

Valuation Metrics : PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Management Effectiveness

The roa for Qiagen N.V. as of 30 June 2025 is 0.02.
The roe for Qiagen N.V. as of 30 June 2025 is 0.11.
The roic for Qiagen N.V. as of 30 June 2025 is 0.02.
The croic for Qiagen N.V. as of 30 June 2025 is 0.03.
The ocroic for Qiagen N.V. as of 30 June 2025 is 0.14.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30	0.02	0.11	0.02	0.03	0.14
2025-03-31	0.01	0.03	0.02	-0.00	0.14
2024-12-31	0.01	0.02	0.02	-0.00	0.14
2024-09-30	0.02	0.03	0.02	0.07	0.12
2024-06-30	0.05	0.09	0.06	0.03	0.10
2024-03-31	0.05	0.10	0.06	-0.01	0.08
2023-12-31	0.07	0.15	0.09	-0.13	0.09
2023-09-30	0.08	0.15	0.09	-0.02	0.10
2023-06-30	0.08	0.15	0.09	-0.02	0.10
2023-03-31	0.07	0.16	0.09	-0.07	0.11
2022-12-31	0.07	0.14	0.08	-0.03	0.13
2022-09-30	0.09	0.15	0.09	0.12	0.15
2022-06-30	0.09	0.17	0.10	-0.01	0.14
2022-03-31	0.09	0.19	0.10	-0.00	0.14
2021-12-31	0.10	0.18	0.10	0.06	0.14
2021-09-30	0.10	0.22	0.12	0.03	0.12
2021-06-30	0.09	0.20	0.10	0.01	0.12
2021-03-31	0.09	0.18	0.09	0.03	0.11
2020-12-31	0.07	0.14	0.07	-0.01	0.09
2020-09-30	0.04	0.08	0.04	-0.05	0.06
2020-06-30	0.00	0.01	0.00	0.02	0.09
2020-03-31	-0.01	-0.01	-0.01	0.03	0.07

Gross Margins

The gross margin for Qiagen N.V. as of 30 June 2025 is 0.67.
The net margin for Qiagen N.V. as of 30 June 2025 is 0.05.
The operating margin for Qiagen N.V. as of 30 June 2025 is 0.26.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30	0.67	0.05	0.26
2025-03-31	0.67	0.04	0.25
2024-12-31	0.67	0.04	0.25
2024-09-30	0.66	0.05	0.24
2024-06-30	0.66	0.17	0.23
2024-03-31	0.66	0.17	0.23
2023-12-31	0.66	0.25	0.23
2023-09-30	0.66	0.25	0.23
2023-06-30	0.67	0.25	0.23
2023-03-31	0.68	0.25	0.24
2022-12-31	0.68	0.20	0.27
2022-09-30	0.67	0.21	0.29
2022-06-30	0.67	0.23	0.29
2022-03-31	0.68	0.23	0.30
2021-12-31	0.68	0.23	0.30
2021-09-30	0.69	0.27	0.29
2021-06-30	0.69	0.22	0.30
2021-03-31	0.69	0.22	0.30
2020-12-31	0.70	0.19	0.29
2020-09-30	0.70	0.11	0.27
2020-06-30	0.71	0.01	0.24
2020-03-31	0.70	-0.02	0.19

GB:QIAD
MX:QIA N
IT:1QGEN	€ 40,31
AT:QGE3
US:QGEN	US$ 47,55
DE:QIA	€ 40,44
GB:0RLT